Table 2.

The ROC analysis of HbA1c and FPG values at years −1 and −2 and the difference between each measure at years −1 and −2 for detecting the first clinic visit in the diabetes group.

Events / nThe time point in the trajectory AUC (95% CI)P-valueP-valueCutoff point §Sensitivity (%)Specificity (%)
HbA1c (%) (mmol/mol)451 / 1,537Year −10.813 (0.790–0.836)Reference6.501 (47.53)69.280.8
Year −20.728 (0.701–0.755)<0.0001Reference6.201 (44.27)71.263.2
(year −1)–(year −2)0.686 (0.654–0.719)<0.00010.08240.201 (2.19)58.375.0
FPG (mmol/L)279 / 1,035year − 10.680 (0.643–0.718)Reference7.16149.877.3
Year −20.595 (0.557–0.634)<0.0001Reference6.71749.165.2
(year −1)–(year −2)0.631 (0.592–0.671)0.00430.25780.33456.366.4
Events / nThe time point in the trajectory AUC (95% CI)P-valueP-valueCutoff point §Sensitivity (%)Specificity (%)
HbA1c (%) (mmol/mol)451 / 1,537Year −10.813 (0.790–0.836)Reference6.501 (47.53)69.280.8
Year −20.728 (0.701–0.755)<0.0001Reference6.201 (44.27)71.263.2
(year −1)–(year −2)0.686 (0.654–0.719)<0.00010.08240.201 (2.19)58.375.0
FPG (mmol/L)279 / 1,035year − 10.680 (0.643–0.718)Reference7.16149.877.3
Year −20.595 (0.557–0.634)<0.0001Reference6.71749.165.2
(year −1)–(year −2)0.631 (0.592–0.671)0.00430.25780.33456.366.4

Individuals with missing measurements at years −1 and −2 were excluded from the analysis.

Year 0 was defined as the year of the first clinic visit or end of follow-up, year −1 was defined as the time point 1 year back from year 0, and year −2 was defined as the time point 2 years back from year 0.

§Cutoff points were determined by maximizing sensitivity plus specificity.

AUC, area under the ROC curve; CI, confidence interval; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin.

Table 2.

The ROC analysis of HbA1c and FPG values at years −1 and −2 and the difference between each measure at years −1 and −2 for detecting the first clinic visit in the diabetes group.

Events / nThe time point in the trajectory AUC (95% CI)P-valueP-valueCutoff point §Sensitivity (%)Specificity (%)
HbA1c (%) (mmol/mol)451 / 1,537Year −10.813 (0.790–0.836)Reference6.501 (47.53)69.280.8
Year −20.728 (0.701–0.755)<0.0001Reference6.201 (44.27)71.263.2
(year −1)–(year −2)0.686 (0.654–0.719)<0.00010.08240.201 (2.19)58.375.0
FPG (mmol/L)279 / 1,035year − 10.680 (0.643–0.718)Reference7.16149.877.3
Year −20.595 (0.557–0.634)<0.0001Reference6.71749.165.2
(year −1)–(year −2)0.631 (0.592–0.671)0.00430.25780.33456.366.4
Events / nThe time point in the trajectory AUC (95% CI)P-valueP-valueCutoff point §Sensitivity (%)Specificity (%)
HbA1c (%) (mmol/mol)451 / 1,537Year −10.813 (0.790–0.836)Reference6.501 (47.53)69.280.8
Year −20.728 (0.701–0.755)<0.0001Reference6.201 (44.27)71.263.2
(year −1)–(year −2)0.686 (0.654–0.719)<0.00010.08240.201 (2.19)58.375.0
FPG (mmol/L)279 / 1,035year − 10.680 (0.643–0.718)Reference7.16149.877.3
Year −20.595 (0.557–0.634)<0.0001Reference6.71749.165.2
(year −1)–(year −2)0.631 (0.592–0.671)0.00430.25780.33456.366.4

Individuals with missing measurements at years −1 and −2 were excluded from the analysis.

Year 0 was defined as the year of the first clinic visit or end of follow-up, year −1 was defined as the time point 1 year back from year 0, and year −2 was defined as the time point 2 years back from year 0.

§Cutoff points were determined by maximizing sensitivity plus specificity.

AUC, area under the ROC curve; CI, confidence interval; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close